title: Rituximab for the treatment of type II mixed cryoglobulinemia.
authors.forename: F
authors.initials: F
authors.lastname: Zaja
authors.forename: D
authors.initials: D
authors.lastname: Russo
authors.forename: G
authors.initials: G
authors.lastname: Fuga
authors.forename: F
authors.initials: F
authors.lastname: Patriarca
authors.forename: A
authors.initials: A
authors.lastname: Ermacora
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab